CHINA PHARMA HOLDINGS, INC. Debt Instrument, Redemption Price, Percentage
CHINA PHARMA HOLDINGS, INC. (CPHI) had Debt Instrument, Redemption Price, Percentage of 82.00% as of 2024-12-09, per its 10-K filed 2026-04-01.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. debt instrument, redemption price, percentage for fiscal 2023 was 82.00%.
| Period end | Debt Instrument, Redemption Price, Percentage | Debt Instrument, Redemption Price, Percentage 9 month | Debt Instrument, Redemption Price, Percentage 12 month |
|---|---|---|---|
| 2024-12-09 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-11-04 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-10-01 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-09-11 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-06-17 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-05-20 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-04-17 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-04-02 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-02-16 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-02-01 | 82.00% 10-K · filed 2026-04-01 | ||
| 2024-01-11 | 82.00% 10-K · filed 2026-04-01 | ||
| 2023-12-31 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-12-13 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-11-30 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-11-29 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-11-06 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-10-17 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-10-12 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-10-06 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-09-30 | 82.00% 10-Q · filed 2023-11-13 | ||
| 2023-09-12 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-09-01 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-08-21 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-08-09 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-06-23 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-06-06 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-05-24 | 82.00% 10-K · filed 2024-04-01 | ||
| 2023-05-01 | 85.00% 10-K · filed 2024-04-01 | ||
| 2023-04-07 | 85.00% 10-K · filed 2024-04-01 | ||
| 2023-03-02 | 85.00% 10-K · filed 2024-04-01 | ||
| 2023-01-18 | 85.00% 10-K · filed 2024-04-01 | ||
| 2023-01-05 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-12-14 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-12-13 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-12-05 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-12-01 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-10-17 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-08-03 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-06-13 | 85.00% 10-K · filed 2024-04-01 | ||
| 2022-03-30 | 85.00% 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |